Rice Hall James & Associates, LLC Ocuphire Pharma, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.54 Billion
- Q2 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 223,589 shares of OCUP stock, worth $288,429. This represents 0.02% of its overall portfolio holdings.
Number of Shares
223,589
Previous 291,985
23.42%
Holding current value
$288,429
Previous $586,000
41.64%
% of portfolio
0.02%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding OCUP
# of Institutions
42Shares Held
2.74MCall Options Held
2KPut Options Held
2K-
Vanguard Group Inc Valley Forge, PA992KShares$1.28 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA266KShares$342,9510.0% of portfolio
-
Richmond Brothers, Inc. Jackson, MI191KShares$246,7820.6% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX164KShares$211,2250.01% of portfolio
-
Black Rock Inc. New York, NY107KShares$137,9460.0% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $26.5M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...